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pression and cell branching. This demonstrates selec-
Wnt genes are involved in tumour growth and regu- tivity of regulation of individual members of the Wnt
late cell adhesion. Some (Wnt5a and Wnt7b) are more gene family by the ras pathway. Overexpression of c-
highly expressed in human breast cancer compared to erbB2 had no effect on Wnt5a or Wnt7b mRNA expres-
normal tissues. Wnt5a is involved in the regulation of sion. Thus, extracellular matrix and ras regulate
cell movement in Xenopus and is upregulated in sev- Wnt5a, providing a mechanism for feedback of mor-
eral human cancers. Factors regulating Wnt gene ex- phogenetic movements, which is relevant also to can-
pression in human breast epithelium are poorly un- cer biology. q 1997 Academic Press
derstood, but c-erbB2 is ampli®ed in many breast can- Key Words: Wnt5a; Wnt7b; c-Ha-ras; regulation;
cers and associated with rapid growth and metastasis, MCF-10A.
as is high expression of c-Ha-ras. To further under-
stand the regulation of Wnt gene expression, this study
investigated the effect of proto-oncogenes c-Ha-ras
and c-erbB2, and collagen on Wnt mRNA expression, Wnt genes encode a family of developmentally highly
in a normal spontaneously immortalised human mam- conserved cysteine-rich glycoproteins of 45 kDa that
mary epithelial cell line MCF-10A. Out of nine human is present in invertebrates and vertebrates (1). The
Wnt genes investigated, Wnt5a and Wnt7b were ex- Wnt proteins are secreted and act in a paracrine and/pressed in the parental cell line, and neomycin-, c-Ha- or autocrine manner, like growth factors, to elicit bio-ras- and c-erbB2-transfected cell lines. The level of
logical responses associated with normal develop-Wnt5a mRNA expression was decreased 40-fold and 3-
mental processes as well as cell proliferation and differ-fold when parental cells were grown on collagen and
entiation (1,2). The mechanism of action of Wnts in-in collagen, respectively. This downregulation corre-
volves signalling via frizzled and dishevelled. In vitrolated with cell branching. However, Wnt7b was not
murine Wnt1 has been shown to regulate b-cateninregulated by collagen. In the presence of activated c-
pool size and stabilise b-catenin/cadherin complexes,Ha-ras, the level of Wnt5a mRNA expression was mark-
which are also known to be associated with tumour celledly decreased ( 200-fold) and cell growth rate was
invasion (3-6). Wnt1 causes partial transformation ofelevated. When treated with p21ras inhibitor, BZA-5B,
mammalian epithelial cell lines (7), affects the cell mor-there was a moderate reversal of Wnt5a mRNA expres-
phology in the mouse embryonic ®broblast cell line C3Hsion (2-fold) with a parallel decrease in cell growth.
10T1/2 (8) and alters the cell morphology induced byThe data indicate that c-Ha-ras is an upstream inhibi-
tory regulator of Wnt5a, and provide further evidence growth factors via the MAP kinase pathway in the rat
of an inverse relationship between Wnt5a mRNA ex- pheochromocytoma cell line, PC12 (9). In Xenopus
laevis, Wnts are involved in the normal axis formation
and their selectivity resides in the C-terminal regions
(10). Wnts act co-operatively with basic ®broblast1 This work was funded by the Imperial Cancer Research Fund.
2 To whom correspondence and reprint requests should be ad- growth factor (bFGF) to determine embryonic pattern
dressed at Imperial Cancer Research Fund, University of Oxford, (11). In vivo the introduction of mouse mammary epith-Institute of Molecular Medicine, John Radcliffe Hospital, Head-
ilia producing Wnt1 into reconstituted mammary glandington, Oxford OX3 9DU, United Kingdom. Fax: /44 1865 222431.
E-mail: aharris.lab@icrf.icnet.uk. induces hyperplasia that is hormonally independent
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South San Francisco, CA 94080, USA and was prepared by dissolving(12). The same phenotypic change has also been seen in
in dimethylsulfoxide (DMSO) / dithiothreitol (DTT). All laboratorymouse mammary tumour virus (MMTV)-induced Wnt1
reagents were from Sigma unless otherwise stated.activation in C3H mouse mammary gland which subse-
Cell culture and RNA preparation. MCF-10A cells were grownquently leads to adenocarcinoma after a latent period
in Dulbecco's modi®ed Eagle's medium (DMEM) / Ham's F-12 (1:1)(13), and in Wnt1 transgenic mice (14). The rate of medium (Imperial Cancer Research Fund Clare Hall Laboratories,
Wnt1-induced mammary hyperplasia is increased in U.K.) supplemented with 10% fetal calf serum (Globepharm), 20 mg/
Wnt1/FGF3 bitransgenic mice indicating a co-operative ml insulin, 0.5 mg/ml hydrocortisone and 10 ng/ml epidermal growth
factor (24). Total RNA was prepared from cells using the acid quanid-role of Wnt and FGF in the murine breast tumourigen-
ium thiocyanate-phenol-chloroform extraction method (26), followedesis (15).
by a 5.7 M caesium chloride separation in polyallomer tubes (13 1In humans, the Wnt5a mRNA level is increased in 51 mm, Beckman) at 50 K rpm for 3 hours using SW50 or SW55
breast, colon, lung and prostate carcinomas and mela- swing rotor (Beckman) in the L8-80M ultracentrifuge (Beckman).
noma versus normal tissues (16,17), Wnt7b is increased The RNA pellet was resuspended in 200 ml of sterile water, treated
with RNase-free DNase at 377C for 15 minutes, extracted with anin breast cancer (18), Wnt2 in colon carcinoma and
equal volume of phenol, ethanol precipitated with 0.11 volume ofbreast ®broadenoma and Wnt4 in breast ®broadenoma
sodium acetate pH 5.2 and resuspended in water to the ®nal volume(18,19). Altogether the data suggest the role of some of 1 mg/ml.
Wnt genes in the progression of human malignancy.
Cell culture in the presence of collagen. Cells were grown on colla-Several factors have been reported to down-regulate
gen by spreading out 3 ml per 10 cm diameter culture plate of colla-
Wnt4 and Wnt5a gene expression in vitro including gen prepared as instructed by the manufacturer (Invitrogen), allowed
bFGF protein, int-2 gene, Wnt1 gene, Wnt2 gene and to set at room temperature for 30 min and then 10 ml of resuspended
cells in culture medium were poured gently on top. For cells growingmutated neu tyrosine kinase receptor gene transfec-
in collagen, 0.3 ml of resuspended cells in culture medium weretion. Furthermore, the down-regulation of Wnt4 and
mixed with 3 ml of collagen, and then poured gently onto a 10 cmWnt5a is inversely related to cell proliferation (20). Dis- diameter culture plate. Collagen was allowed to set in a 377C humidi-
ruption of the cytoskeleton or treatment with hepato- ®ed incubator for 30 min and then 10 ml of culture medium was
cyte growth factor can also down-regulate Wnt5a poured gently on top. Cells were plated out at 100% con¯uence, fed
after 2 days and harvested 4 days post-plating. For cells grown onmRNA level in the immortalised human mammary epi-
collagen or in collagen, 5 ml of collagenase 1 mg/ml was added tothelial cell line, HB2. This Wnt5a down-regulation is
the plate to digest collagen to completion in the incubator prior toassociated with cell branching. At con¯uence, Wnt5a harvesting.
mRNA level is increased (21). In Xenopus laevis, Wnt5a
Subcon¯uence and con¯uence growth, and treatment with BZA-has been shown to block the elongation of blastula caps
5B. In the subcon¯uence and con¯uence experiments, MCF-10A
(22). The data suggest that in vitro Wnt5a acts as a cells were plated out at an equal density to about 50% con¯uence
modulator of cell migration and its gene expression is and allowed to grow until 80% con¯uence (subcon¯uence) or 100%
con¯uence. The BZA-5B treatment experiment was carried out inregulated by multiple factors.
triplicate on 10-cm plates. Again, MCF-10A cells were plated out atTherefore to extrapolate from these data, the level
an equal density to about 50% con¯uence to which the followingof Wnt5a mRNA would be expected to be low in cancer
was added: 50 mM BZA-5B, DMSO/DTT (solvent control) or culture
tissues in vivo compared to corresponding normal tis- medium alone. Every 3 days, the medium was replaced with fresh
sues. However, the opposite has been reported in sev- medium containing an appropriate treatment. Total RNA was then
harvested at day 5.eral human cancers (16-19). The discrepancy of Wnt5a
mRNA expression level between in vivo and in vitro Treatment with BZA-5B and cell count. MCF-10A cells were
suggests the need to understand further the factors plated out in triplicate at a density of 300 cells per well in the 24-
well plate. The cells were either untreated or treated with solventthat regulate Wnt5a mRNA expression and the path-
alone or 50 mM BZA-5B. A fresh medium was replaced every threeways controlling the basal level of Wnt5a mRNA. We
days. Every 24 hours post-plating, 3 wells from either MCF-10Awt,studied the spontaneously immortalised human breast MCF-10Aneo or MCF-10AneoT cell lines were trypsinised in 0.5ml
epithelial cell line, MCF-10A, which represents the nor- volume, and transferred to 9.5ml Isoton II (Coulter). The cell number
was counted using the coulter counter ZM (Coulter) from which themal human luminal mammary epithelial cells (23), the
absolute read out was recorded.effects of extracellular matrix and oncogenes known to
be involved in human breast cancer either via gene Ribonuclease (RNase) protection analysis. The human Wnt5a
(21), Wnt10b (27) and Wnt 2, 3, 3a, 4, 7b and glyceraldehyde-3-ampli®cation (erb-B2) or high expression (H-ras).
phosphate dehydrogenase (GAPDH) (18) have been described. The
linearised Wnt and GAPDH plasmid DNAs were labelled with [a-
MATERIALS AND METHODS 32P]CTP to generate antisense riboprobes which were then puri®ed
using the spin column according to the manufacturer's instructions
(Boehringer Mannheim). RNase protection analysis was performedMaterials. Parental MCF-10A cell line (MCF-10Awt), and its de-
rivatives containing the neomycin-resistant gene (MCF-10Aneo) or on 10 mg of total RNA at 457C using standard protocols (28). Autoradi-
ography was done at0707C with intensifying screens. Yeast transferthe human T24-mutated c-Ha-ras oncogene (MCF-10AneoT) have
been described (24). MCF-10Aneo and MCF-10AneoT cells contained RNA (Boehringer Mannheim) was used as a negative control. The
protected fragment signals for Wnt and GAPDH were quanti®ed bya pool of 30 isolated colonies each and were used in the study. MCF-
10A c-erbB2 cell line has been established previously (25). BZA-5B laser densitometry using a Bio Image analyser (Millipore). GAPDH
was used as an internal loading control.compound (mw  571 g/mol) was obtained from Genentech Inc.,
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TABLE 1 was very low in MCF-10AneoT cells (Fig. 2, C). Fig. 2,
B shows the change of morphology when MCF-10An-Wnt mRNA Expression in MCF-10A Wild Type
and Transfectants eoT cells were grown in 3 different conditions. Collagen
had no effect on the level of Wnt7b mRNA expression
Wnt 2 3 3a 4 5a 7a 7b 10b in or between MCF-10Aneo and MCF-10AneoT on plas-
tic, on collagen or in collagen (data not shown). There-MCF-10Awt 0 0 0 0 // 0 / 0
fore, collagen down-regulated Wnt5a mRNA expressionMCF-10Aneo 0 0 0 0 // 0 / 0
selectively.MCF-10AneoT 0 0 0 0 / 0 / 0
MCF-10A c-erbB2 0 0 0 0 // 0 / 0
Wnt5a mRNA expression is not regulated by con¯u-
ence. The effect of cell density on Wnt5a mRNA ex-//  high expression, /  low expression, 0  no expression.
pression was investigated since it was previously re-
ported that con¯uence upregulates Wnt5a mRNA level
in HB2 cells (21). The cells were plated out on plasticStatistical analysis. The level of Wnt mRNA expression was cal-
at a subcon¯uence density and were harvested at theculated as a ratio of Wnt/GAPDH protected fragment signals. The
level of expression of Wnt5a in BZA-5B treated and untreated cells following times: 0.5, 1, 2, 3 and 5 days. There was no
was compared using Student's unpaired t-test from the Minitab ver- change in Wnt5a mRNA level throughout the time
sion 8.2. course in MCF-10Aneo or MCF-10AneoT (data not
shown). Therefore, con¯uence had no effect on Wnt5a
RESULTS mRNA expression.
Reversal of Wnt5a mRNA down-regulation in MCF-
Wnt mRNA expression in MCF-10A wild type and 10AneoT cell line by BZA-5B. BZA-5B, a farnesyl protein
transfectants. Table 1 summarises the Wnt mRNA ex- transferase inhibitor that has been shown to block speci®-
pression in MCF-10Awt, MCF-10Aneo, MCF-10AneoT cally the synthesis of biological active p21ras protein and
and MCF-10A c-erbB2 cell lines. The constitutive ex- subsequently reversed the abnormal cell growth induced
pression of mutated c-Ha-ras in MCF-10AneoT cells by activated H-ras(Gly12Val) (29). Fig. 3, B shows that
resulted in a signi®cant down-regulation ( 200-fold) BZA-5B inhibited the abnormal cell growth in MCF-10An-
of Wnt5a mRNA level compared to MCF-10Awt and eoT cells at day 4 by45% compared to no treatment and
MCF-10Aneo (Fig. 1). Overexpression of c-erbB2 had by56% at day 7. The reduced cell growth led to a sparse
no effect on Wnt5a mRNA expression compared to cell population in BZA-5B treated MCF-10AneoT cells
MCF-10Awt and MCF-10Aneo. The level of Wnt7b compared to untreated (data not shown). This was associ-
mRNA was constant in all MCF-10A cell lines. Wnt 2, ated with a moderate increase in the Wnt5a mRNA level
3, 3a, 4, 7a and 10b mRNAs were not detected in any (mean  2-fold) in BZA-5B treated MCF-10AneoT cells
MCF-10A cell line. The results were obtained from cells
growing to con¯uence on plastic surface, and showed
that mutated c-Ha-ras down-regulates Wnt5a mRNA
expression.
Effects of Wnt5a and Wnt7b mRNA expression in the
presence of collagen. One pathway by which the above
effects may be mediated is signalling from the extracel-
lular matrix and changes in cell adhesion which charac-
teristically occur in transformed cells and cancer.
Therefore, the effect of collagen on Wnt5a and Wnt7b
mRNA expression was investigated. The cells were
plated out at a con¯uence density and allowed to grow
for four days prior to harvest. There was a 40-fold and
3-fold down-regulation of Wnt5a mRNA level in MCF-
10Aneo cells grown on collagen and in collagen, respec-
tively, compared to on plastic (Fig. 2, C). The Wnt5a
down-regulation was correlated with the appearance of
increased cell branching (Fig. 2, A). In the MCF-10An- FIG. 1. RNase protection analysis showing the downregulation
of Wnt5a mRNA expression in MCF-10AneoT. wt  MCF-10Awt,eoT cells, the level of Wnt5a mRNA was also lower in
neo  MCF-10Aneo and neoT  MCF-10AneoT. 20 mg of total RNAcells grown on collagen compared to on plastic, and was
was used in neoT whereas 10 mg was used in wt and neo. Total RNAapproximately equal in cells grown in collagen com- was incubated with antisense Wnt5a riboprobe at 457C, digested
pared to growth on plastic. This was dif®cult to quan- with RNaseA, separated onto a 6% polyacrylamide/urea gel and auto-
radiographed.tify since the intensity of Wnt5a protected fragment
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FIG. 2. Effect of MCF-10A in the presence of collagen. The morphology of MCF-10Aneo (A) and MCF-10AneoT (B) cells in different
culture conditions: OP  on plastic, OC  on collagen and IC  in collagen. Magni®cation 1001. (C) RNase protection analysis showing
the corresponding level of Wnt5a mRNA. The level of Wnt5a mRNA was expected to be low in neoT (see Fig. 1). neo  MCF-10Aneo and
neoT  MCF-10AneoT.
compared to untreated (P  0.001) (Fig. 3, C & E). This sion of human malignancy. The mechanism of their ac-
tion is not yet fully understood, although in vitro Wnt1experiment was performed in triplicate and repeated twice
in which a similar degree of reversal of Wnt5a mRNA has been demonstrated to act via cell adhesion molecules
(5,6) and to increase cell proliferation (20). Recently welevel was seen in MCF-10AneoT treated cells. BZA-5B
had no effect on cell growth inhibition and Wnt5a mRNA have used a normal human mammary epithelial cell line,
level in MCF-10Aneo cells (Fig. 3, A & D). Therefore, inhi- HB2, which has been immortalised with the T antigen
bition of the sysnthesis of biological active p21ras protein of SV40, to demonstrate the association of Wnt5a gene
led to a moderate reversal of Wnt5a mRNA level in MCF- down-regulation with cell branching (21). In this study,
10AneoT but not MCF-10Aneo cells. we examined a normal spontaneously immortalised hu-
man mammary epithelial cell line, MCF-10A (23), and
DISCUSSION showed that the down-regulation of Wnt5a mRNA level
is also associated with cell branching. This occurred whenWnts are a group of novel growth factors that play a
role in mouse tumourigenesis and possibly in the progres- cells were grown in the presence of collagen suggesting
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FIG. 3. Effect of BZA-5B on MCF-10A cell growth and Wnt5a mRNA expression. Cell growth of MCF-10Aneo (A) and MCF-10AneoT
(B), and the corresponding Wnt5a mRNA expression on treatment with 50 mM of BZA-5B (C) detected by RNase protection analysis (see
Fig. 1). The level of Wnt5a mRNA expression was quanti®ed and represented in (D) for MCF-10Aneo and (E) for MCF-10AneoT. control 
pooled samples of untreated and DMSO, *  signi®cant difference. 20 mg total RNA was used in all MCF-10AneoT cells compared to 10
mg in MCF-10Aneo to enhance the density of Wnt5a protected fragment.
that there is an association of extracellular matrix (ECM) Parental MCF-10A cells expressed only Wnt5a and
Wnt7b genes of the Wnt genes analysed, both of whichsignalling and the down-regulation of Wnt5a in the
breast epithelial cells. have been reported to be elevated in human breast
915
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cancers (17,18). In this study, activated c-erbB2 had no (21,22). However, our result here still cannot explain
the marked upregulation of Wnt5a in human cancerseffect on Wnt5a mRNA expression. However, it was
shown that transfection of activated neu tyrosine ki- (16,17). Therefore, this suggests that there must be
other mechanisms upregulating Wnt5a in cancer.nase receptor gene down-regulated Wnt5a mRNA ex-
pression in a mouse breast cancer cell line (20). There-
fore, this contrasting result highlights the necessity to REFERENCES
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